Build status - In Progress

Study to Assess Pulsed, Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated with Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2)

Recruiting
18 years - 80 years
All
5 participants needed
1 Location

Brief description of study

The purpose of this study is to determine if the INOpulse® delivery system, that includes the INOpulse® device, inhaled nitric oxide study drug as delivered via triple lumen nasal cannula can help treat patients with fibrotic interstitial lung disease (fILD) who are on oxygen therapy and who are at risk of having or developing pulmonary hypertension associated with pulmonary fibrosis (PH-PF). Specifically, the study will determine if the use of the INOpulse® delivery system can help improve daily levels of moderate to vigorous types of physical activity (for example walking, climbing stairs, household chores and cleaning and, exercise and hobbies), as measured by an activity monitor (a non-invasive way to monitor rest/activity).

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: interstitial lung disease,ILD,Pulmonary Hypertension,Pulmonary Fibrosis
  • Age: 18 years - 80 years
  • Gender: All
Updated on 04 Aug 2024. Study ID: 850447

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center